Advancing Luciferase-Based Antibody Immunoassays to Next-Generation Mix and Read Testing
Open Access
- 21 February 2023
- journal article
- review article
- Published by MDPI AG in Biosensors
- Vol. 13 (3) , 303
Abstract
Antibody measurements play a central role in the diagnosis of many autoimmune and infectious diseases. One antibody detection technology, Luciferase Immunoprecipitation Systems (LIPS), utilizes genetically encoded recombinant luciferase antigen fusion proteins in an immunoglobulin capture format to generate robust antibody measurement with high diagnostic sensitivity and specificity. The LIPS technology has been highly useful in detecting antibodies for research diagnostics and the discovery of new autoantigens. The methodology of the assay requires immunoglobulin binding reagents such as protein A/G beads and washing steps to process the immune complex before antibody levels are measured by light production with a luminometer. Recently, simplified mix and read immunoassays based on split components of the nanoluciferase enzyme in a complementation format have been developed for antibody measurements without requiring immunoglobulin-capturing beads or washing steps. The mix and read immunoassays utilize two or three nanoluciferase fragments which when reconstituted via antigen-specific antibody binding generate a functional enzyme. At present, these split luciferase tests have been developed mainly for detecting SARS-CoV-2 antibodies. Here, we describe the traditional LIPS technology and compare it to the new split luciferase methodologies focusing on their technical features, strengths, limitations, and future opportunities for diagnostic research, and clinical applications.Keywords
Funding Information
- Intramural Research Program of the National Institute of Dental and Craniofacial Research and the Clinical Center, NIH (ZIA CL090034-10)
This publication has 83 references indexed in Scilit:
- Comprehensive serological profiling of human populations using a synthetic human viromeScience, 2015
- Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseasesTranslational Research, 2015
- SP140L, an Evolutionarily Recent Member of the SP100 Family, Is an Autoantigen in Primary Biliary CirrhosisJournal of Immunology Research, 2015
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Adult-Onset Immunodeficiency in Thailand and TaiwanNew England Journal of Medicine, 2012
- Anti-Ro and anti-La autoantibody profiling in Norwegian patients with primary Sjögren’s syndrome using luciferase immunoprecipitation systems (LIPS)Scandinavian Journal of Rheumatology, 2012
- Autoantigen discovery with a synthetic human peptidomeNature Biotechnology, 2011
- Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasiaBlood, 2010
- Sensitive and robust luminescent profiling of anti-La and other autoantibodies in Sjögren's syndromeAutoimmunity, 2009
- Secretional luciferase of the luminous shrimpOplophorus gracilirostris: cDNA cloning of a novel imidazopyrazinone luciferaseFEBS Letters, 2000